Search

everythinglearnresearchcommunity

for

Search:↓

Personalized treatment based on detailed tumor analysis successfully managed and reduced the patient's aggressive hair follicle cancer.

Non-white organ transplant patients have worse skin cancer outcomes due to later diagnosis and treatment.

A woman with dermatomyositis improved after treatment for neck panniculitis, suggesting similar treatment for related conditions.

Cancer cells often have more copies of TERT and TERC genes, which helps them grow and could affect patient outcomes.

The document concludes that systemic therapy is becoming more important in treating head and neck cancer, with new treatments showing promise.

Sporadic trichoblastic neoplasms generally don't recur or spread, with one case showing a specific genetic fusion.

Brain hormones significantly affect hair color and could potentially be used to prevent or reverse grey hair.

Late puberty may slightly lower prostate cancer risk, baldness is not linked to overall risk but less so with aggressive types, ibuprofen use may increase risk, and vitamins show no effect on risk.

A boy with chromosome 13q deletion syndrome developed eye cancer, a woman with breast cancer lost vision due to a rare side-effect of her treatment, a man's vision worsened after using a hair loss drug, and two rare disorders were discussed. Optical Coherence Tomography is useful for diagnosing and monitoring these conditions.

Eye exams are crucial for kids with 13q deletion syndrome, tamoxifen can cause vision loss, Propecia may lead to cataracts, Lipoid Proteinosis causes skin bumps, and OCT is useful for diagnosing macular diseases.

Sorafenib can cause facial acne-like eruptions, which improve after reducing the dose or stopping the drug.

New treatments targeting the Hedgehog pathway can help treat advanced skin cancer but may have side effects and their effectiveness in early stages is unknown.

Immune checkpoint inhibitors can cause skin issues but are linked to better cancer outcomes.

A baby boy with 13q deletion syndrome had eye cancer, a woman's vision improved after stopping a breast cancer drug, a man developed cataracts from using Propecia, and a rare skin disorder called Lipoid Proteinosis was discussed. Also, a tool called OCT is useful for diagnosing macular diseases.

Nanotechnology is improving drug delivery and targeting, with promising applications in cancer treatment, gene therapy, and cosmetics, but challenges remain in ensuring precise delivery and safety.

The document discusses various eye conditions and their treatments, including a rare eye cancer in a baby, vision loss from a cancer drug, cataracts from a baldness treatment, a rare skin disorder, and a specific type of eye disease diagnosed with a special imaging technique.

Finasteride, often used for hair loss, can potentially cause cataracts.

Vesiculobullous lesions should be considered part of canine cutaneous epitheliotropic T-cell lymphoma.

VEGF helps squamous cell carcinoma grow in ways beyond just blood vessel formation.

Monocyclic aromatic compounds are important for developing various drugs and treatments.

CEC levels may be a useful marker for predicting prostate cancer progression.

The European School of Oncology organized various educational events in 1994, highlighting important cancer research findings.

Septin4 helps kill colon cancer cells by working with the protein BAX.

The document explains hair and nail biology, common hair loss conditions and treatments, oral and genital skin diseases, and the risks and treatments associated with squamous cell carcinoma.

Minoxidil and ranolazine together can reduce the spread of certain breast cancer cells.

Wedelolactone may help prevent bone damage in breast cancer by blocking certain cell signals.

A man developed temporary hair loss after taking a cancer drug, which might indicate a better treatment response.

EGFR inhibitors often cause skin issues like acne and dryness, which can be managed with specific treatments.

Lenvatinib and sorafenib are generally safe but need dose adjustments due to side effects.

Gefitinib can cause scalp skin issues and permanent hair loss.